UK digital medical company Congenica is launching the development of a ground-breaking, innovative CE-IVD Precision Oncology Solution with the help of GenomOncology’s Precision Oncology Platform.

The popularisation of cancer genomics, as well as the strong demand for the personalization of therapeutic recommendations, has led to the development of an automated data analysis application that is practical and adaptive to large-scale genomic data in oncology practice.

This platform aims to harmonize up-to-date information in the field of oncology, which integrates:

• annotations and ontologies,
• private content and datasets.

With the launch of this knowledge base, the company will have greater access to oncology information from the US, the UK, the European Union, and other countries. This will enable ideas and recommendations to be generated in response to the information received.

Congenica’s product is a practical and forward-looking solution that unlocks the full potential of precision oncology. GenomOncology has extensive experience in this field and its new product is specifically designed to provide effective solutions for diagnosing and treating cancer. This project creates an enabling environment for the further development of precision medicine and better patient care.

• Congenica implements rapid analysis and interpretation of genomic data to ensure the most rational treatment for patients. Congenica’s leading software is able to provide large-scale data analysis in the field of rare diseases, hereditary and somatic cancers, as well as non-invasive prenatal diagnostics. The company’s global activities are characterized by the support of international laboratories, academic medical centers, and pharmaceutical companies.
• GenomOncology provides the medical field with data-driven information to improve cancer treatment. The Precision Oncology Platform provides multiple software solutions that positively influence successful outcomes. The platform offers proprietary content, accessible and licensed patient data, and determines the success of diagnosis and treatment.